Assignee
CELISTA PHARMACEUTICALS LLC
US·5 granted patents·7 pending applications·0 citations·filing 2019–2024
Top patents by PatentIndex Score
12 records- 0174US2025161324A1Testosterone and estradiol transdermal sprayCELISTA PHARMACEUTICALS LLC·Filed 2024·Application pending·0 cites
- 0267US12208169B2Testosterone transdermal spray with filmCELISTA PHARMACEUTICALS LLC·Filed 2022·Granted Jan 28, 2025·0 cites·16 claims
- 0365US2024390342A1Antiviral therapy with imiquimod and cocrystals thereofCELISTA PHARMACEUTICALS LLC·Filed 2024·Application pending·0 cites
- 0464US2024325350A1Sprayable liquid spironolactone compositionsCELISTA PHARMACEUTICALS LLC·Filed 2024·Application pending·0 cites
- 0563US12186326B2Testosterone and estradiol transdermal sprayCELISTA PHARMACEUTICALS LLC·Filed 2019·Granted Jan 7, 2025·0 cites·5 claims
- 0663US11976065B2Imiquimod cocrystalsCELISTA PHARMACEUTICALS LLC·Filed 2021·Granted May 7, 2024·0 cites·19 claims
- 0763US2024148640A1Topical oxybutynin for hot flashesCELISTA PHARMACEUTICALS LLC·Filed 2023·Application pending·0 cites
- 0862US11523994B2Testosterone transdermal spray with filmCELISTA PHARMACEUTICALS LLC·Filed 2019·Granted Dec 13, 2022·0 cites·16 claims
- 0959US12076313B2Antiviral therapy with imiquimod and cocrystals thereofCELISTA PHARMACEUTICALS LLC·Filed 2021·Granted Sep 3, 2024·0 cites·10 claims
- 1050US2022347132A1Sprayable liquid lidocaine solutionCELISTA PHARMACEUTICALS LLC·Filed 2020·Application pending·0 cites
- 1147US2022241222A1Atomoxetine hydrochloride extended release compositions and methods of useCELISTA PHARMACEUTICALS LLC·Filed 2020·Application pending·0 cites
- 1246US2021128549A1Oxycodone and methylnaltrexone multiparticulates and suspensions containing themCELISTA PHARMACEUTICALS LLC·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when CELISTA PHARMACEUTICALS LLC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →